Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $2,363.0M | $3,674.0M | $2,950.0M | $3,166.0M | $4,196.0M | $4,605.0M | $4,627.0M | $3,683.0M | $4,345.0M | $5,081.0M | $5,158.0M | $6,939.0M | $7,722.0M | $1,979.0M | $8,394.0M | $7,842.0M | $7,264.0M | $5,893.0M | $6,552.0M | $6,717.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Amgen Inc.'s last 12-month Net Income is $4,230.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Amgen Inc.'s Net Income growth was (44.1%). The average annual Net Income growth rates for Amgen Inc. have been (15.8%) over the past three years, (12.1%) over the past five years.
Over the last year, Amgen Inc.'s Net Income growth was (44.1%), which is lower than industry growth of (0.3%). It indicates that Amgen Inc.'s Net Income growth is Bad.